aTyr Pharma, Inc. Capital Reinvestment Ratio

Latest as of March 2020: 0.08x

aTyr Pharma, Inc. capital reinvestment ratio. aTyr Pharma, Inc. (ATYR) has a Capital Reinvestment Ratio of 0.08x as of March 2020, meaning it reinvests 0% of its operating cash flow ($2.06 Million) in capital expenditures ($166.00K). Check how aggressively does aTyr Pharma, Inc. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.08x

Capex / Operating Cash Flow

Operating Cash Flow

$2.06 Million

USD

Capital Expenditures

$166.00K

USD

Data as of

Mar 2020

Most recent filing

aTyr Pharma, Inc. Capital Reinvestment Ratio by Year (None–None)

aTyr Pharma, Inc. capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash efficiency ratio of aTyr Pharma, Inc..

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow